Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent and tissue-targeted medicines, today announced that it has received U.S. Food and Drug Administration (FDA) ...

Glycogen synthase kinase-3β; Red arrows, suppression; green arrows, promotion. This section mainly generalizes the dual effects of miR-133 on cardiac electrical remodeling. We presume that miR-133 ...

glycogen synthase kinase-3β; MAVS, mitochondrial antivirus signaling protein; TRAF6, TNF receptor-associated factor 6; PD-L1, programmed cell death ligand-1; CRC, colorectal carcinoma; ESCC, ...

Correspondence to Dr Pere Ginès, Liver Unit, Hospital Clinic of Barcelona, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona 08036, Spain; ...

Understanding the molecular mechanisms of insulin resistance remains a major medical challenge of the twenty-first century. Over the last half-century, many hypotheses have been proposed to ...

A new study reveals that even low-dose, chronic exposure to air pollution can trigger liver inflammation, fibrosis, and metabolic disruptions, increasing the risk of fatty liver disease and other ...